US Broker Ratings

Grifols, S.A. (GRFS) Stock Analysis: Potential 34.71% Upside Catches Investor Attention

Grifols, S.A. (NASDAQ: GRFS), a prominent player in the healthcare sector, is capturing the attention of investors with its intriguing market dynamics and forward-looking potential. As a leading provider in..

Exelixis, Inc. (EXEL) Investor Outlook: Navigating a 6.73% Potential Upside in the Biotechnology Sector

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to capture investor interest with its robust oncology portfolio and strategic collaborations. Headquartered in Alameda, California, this company..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Unveiling a 13% Potential Upside for Investors

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a prominent player in the medical technology sector, with a focus on orthopedic reconstructive products and cutting-edge surgical technologies. As of the..

ResMed Inc. (RMD) Stock Analysis: Exploring a 32% Upside Potential for the Healthcare Innovator

For investors seeking to enhance their portfolios with promising healthcare stocks, ResMed Inc. (NYSE: RMD) presents a compelling opportunity. ResMed, a leader in developing innovative medical devices and cloud-based software..

Koninklijke Philips N.V. (PHG) Stock Report: Exploring a 24.46% Upside Potential for Investors

Investors seeking opportunities in the healthcare sector might find Koninklijke Philips N.V. (NYSE: PHG) an intriguing option, especially given its potential upside of 24.46%. With its long-standing reputation as a..

Molina Healthcare Inc (MOH) Investor Outlook: Navigating the Healthcare Plans Sector with a Potential 8% Upside

Molina Healthcare Inc (NYSE: MOH), a pivotal player in the Healthcare Plans industry, presents an intriguing opportunity for investors focused on managed healthcare services. Headquartered in Long Beach, California, Molina..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unveiling a 166% Potential Upside for Investors

Soleno Therapeutics, Inc. (NASDAQ: SLNO) has emerged as a compelling prospect within the biotechnology sector, capturing investor attention with a staggering potential upside of 166.28%. With a current market capitalization..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential with a 4.21% Upside

DaVita Inc. (NYSE: DVA), a major player in the healthcare sector specializing in kidney dialysis services, presents an intriguing prospect for investors with its recent financial performance and analyst projections...

Cytokinetics, Inc. (CYTK) Stock Analysis: Unveiling a Promising 39% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands at the forefront of the biotechnology sector, carving out its niche by focusing on the development of muscle activators and inhibitors to treat debilitating diseases...

Bruker Corporation (BRKR) Stock Analysis: Navigating a 30% Potential Upside in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector’s medical devices industry, presents an intriguing opportunity for investors seeking exposure to scientific and analytical instrumentation. Despite some challenging..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth with a 23% Revenue Surge

Exact Sciences Corporation (NASDAQ: EXAS) is making waves in the healthcare sector with its focus on innovative cancer screening and diagnostics. This Wisconsin-based company has a robust portfolio that includes..

ADMA Biologics Inc (ADMA): Investor Outlook with Potential for 155% Upside

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company focused on plasma-derived therapeutics, has been gaining attention for its promising growth potential within the healthcare sector. With a current market capitalization..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 59% Potential Upside Amidst Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a pioneering entity in the biotechnology sector, is garnering significant attention from investors due to its promising growth potential in the treatment of rare neuroendocrine..

McKesson Corporation (MCK) Stock Analysis: Is the 12.82% Upside an Opportunity for Investors?

McKesson Corporation (NYSE: MCK) stands as a formidable entity within the healthcare sector, specifically in the medical distribution industry. With a market capitalization of $109.14 billion, McKesson is not just..

Labcorp Holdings Inc. (LH) Stock Analysis: Unveiling a 12.63% Potential Upside for Healthcare Investors

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $22.69 billion, Labcorp offers a comprehensive..

Thermo Fisher Scientific Inc (TMO): Investor Outlook with a 34.58% Potential Upside

Thermo Fisher Scientific Inc (NYSE: TMO), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, presents a compelling opportunity for investors seeking growth within a..

Chemed Corp (CHE) Stock Analysis: Navigating a 16.4% Potential Upside in Healthcare

Chemed Corp (NYSE: CHE), a notable player in the healthcare sector, operates at the intersection of hospice care and essential plumbing services. With a market capitalization of $5.37 billion, Chemed’s..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook on a Biotech Powerhouse with a 32.73% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is rapidly emerging as a formidable player in the biotechnology sector, a magnet for investors seeking promising opportunities in the healthcare space. With a robust..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 10.34% Potential Upside in Healthcare Diagnostics

Quest Diagnostics Incorporated (NYSE: DGX), a stalwart in the healthcare diagnostics sector, offers an intriguing opportunity for investors seeking exposure to the diagnostics and research industry. With a current market..

Abbott Laboratories (ABT) Stock Analysis: A Look at 28.59% Potential Upside for Healthcare Investors

Abbott Laboratories (NYSE: ABT), a leading player in the healthcare sector, continues to capture investor attention with its robust portfolio in the medical devices industry. With a market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds